1220910-89-3

• 常用中文名：N-[3-氟-4-[6-(2-甲基-2H-四唑-5-基)-3-吡啶基]苯基]氨基甲酸苄酯
• 常用英文名：N-[3-Fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]carbamic acid phenylmethyl ester
• CAS号：1220910-89-3
• 分子式：C₂₁H₁₇FN₆O₂
• 分子量：404.39700
• 发布时间：2018-12-24 13:34:54
• 更新时间：2026-07-14 01:17:28

名称

• 中文名: N-[3-氟-4-[6-(2-甲基-2H-四唑-5-基)-3-吡啶基]苯基]氨基甲酸苄酯
• 英文名: Benzyl {3-fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phe nyl}carbamate
• 中文别名: (3-氟-4-(6-(2-甲基-2H-四唑-5-基)吡啶-3-基)苯基)氨基碳酸苄酯; 磷酸特地唑胺中间体11; N-[3-氟-4-[6-(2-甲基-2H-四唑-5-基)-3-吡啶基]苯基]氨基甲酸苄; N-[3-氟-4-[6-(2-甲基-2H-四唑-5-基)-3-吡啶基]苯基]氨基甲酸苄酯(特地唑胺杂质); N-(3-氟-4-(6-(2-甲基-2H-四唑-5-基)-3-吡啶基)苯基)氨基甲酸苯甲酯; 特地唑胺杂质68; 特地唑咹中间体N-[3-氟-4-[6-(2-甲基-2H-四唑-5-基)-3-吡啶基]苯基]氨基甲酸苄酯; 特地唑胺杂质; 磷酸泰地唑胺中间体1; 特地唑胺杂质22; N-[3-氟-4-[6-(2-甲基-2H-四唑-5-基)-3-吡啶基]苯基]氨基甲酸苄酯(泰地唑胺中间体); (N-[3-氟-4-[6-(2-甲基-2H-四唑-5-基)-3-吡啶基]苯基]氨基甲酸苄酯)(特地唑咹中间体); 特地唑咹中间体 特地唑咹中间体; (3-氟-4-(6-(2-甲基-2H-四唑-5-基)吡啶-3-基)苯基)氨基甲酸苄酯; 特地唑咹中间体; N-[3-氟-4-[6-(2-甲基-2H-四唑-5-基)-3-吡啶]苯基]-氨基甲酸苯甲酯
• 英文别名: Benzyl {3-fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phe nyl}cbamate; (S)-1-CBZ-AMINO-BUTYL-3-AMINE; CbaMic acid, N-[3-fluoro-4-[6-(2-Methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]-, phenylMethyl ester; Tedizolid Impurity 46; Tedizolid Impurity 68; N-[3-fluoro-4-[6-(2-Methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]; benzyl (4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)carbamate; Torezolid-20; benzyl (3S)-3-aminobutylcarbamate; Tedizolid impurity 29/Benzyl (3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)cbamate; S-1-N-CBZ-butane-1,3-diamine; N-[3-fluoro-4-[6-(2-Methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]-, phenylMethyl ester; Torezolid Intermediate1; Tedizolid Phosphate Intermediate; benzyl N-[3-fluoro-4-[6-(2-methyltetrazol-5-yl)pyridin-3-yl]phenyl]cbamate; Benzyl (3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)cbamate (Torezolid Impurity); benzyl (3-fluoro-4-(6-(2-Methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)cbaMate; Terazolamide impurity 22; n-(3-fluoro-4-(6-(2-methyl-2h-tetrazol-5-yl)-3-pyridinyl)phenyl)carbamic acid phenylmethyl ester; Tedizolid impurity581; N-[3-Fluoro-4-[6-(2-Methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]cbaMic acid phenylMethyl ester; Intermediate of Tedazolamide; Trozolamide impurity 40; (S)-BENZYL 3-AMINOBUTYLCARBAMATE; CbaMic acid, N-[3-fluoro-4-[6-(2-Methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]-, phenylMethyl ester ISO 9001：2015 REACH; N- [3- fluoro-4- [6- (2-methyl-2H- tetrazol-5-yl) -3-pyridinyl] phenyl] cbamate cbamic acid; N-[3-Fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phe; N- [3- fluoro-4- [6- (2-methyl-2H- tetrazol-5-yl) -3-pyridinyl] phenyl] cbamate

物化性质

• 分子式: C₂₁H₁₇FN₆O₂
• 分子量: 404.39700
• 精确质量: 404.14000
• PSA: 98.31000
• LogP: 3.84050
• 储存条件: 室温，干燥

合成路线

874290-59-2 380380-64-3 ~87% 1220910-89-3

文献：TRIUS THERAPEUTICS; COSTELLO, Carrie, A.; SIMSON, Jaqueline, A.; DUGUID, Robert, J.; PHILLIPSON, Douglas Patent: WO2010/42887 A2, 2010 ; Location in patent: Page/Page column 18-19 ;

上下游产品

上游产品  2
874290-59-2 380380-64-3
下游产品  1
856866-72-3